|
|
Binance |
|
|
Coinbase |
|
|
KUCOIN |
|
|
AscendEX (Formally BitMax) |
By Trader Edge at 2026-09-15 21:31
Sentiment: Negative
TLDR Moderna and Merck’s mRNA cancer vaccine, intismeran autogene, reduced melanoma recurrence by 49% in a late-stage trial of over 1,000 patients, marking the first successful therapeutic cancer vaccine after 100+ years of failed attempts. MRNA stock opened at $142.77 on Friday, down 4.6%, despite being up over 130% since the vaccine results were announced. [...] The post Moderna (MRNA) Stock: New Cancer Vaccine Sales Could Hit $3B – Time to Buy? appeared first on CoinCentral. Continue reading...
Categories: Stocks
Tags: #Stocks
Source Coin Central